Serum and urinary cytokine levels of SLE patients.

作者: M. Zeher , S. Sipka , G. Szegedi , Boglarka Brugos , Z. Vincze

DOI: 10.1691/PH.2012.1694

关键词:

摘要: Systemic lupus erythematosus (SLE) is a chronic, relapsing, polysystemic autoimmune disease with various clinical signs. The prognosis of SLE patients influenced by neuropsychiatric and renal involvement. Lupus nephritis (LN) present in 40-60% patients. Classical laboratory parameters are not sensitive specific prediction flares, over the last few years there has been growing interest searching novel biomarkers predicting future flares. Our goal was to detect serum urinary level cytokines 36 (34 female 2 male, mean age: 43.36 +/- 11.53 years), 23 without involvement (19 women 4 men, 54 8.71) (both groups followed 3rd Department Internal Medicine, Division Clinical Immunology, University Debrecen) 30 healthy controls (23 7 45.5 12.4). Serum IL-1 (interleukin), IL-2 p < 0.05), IL-6, IL-13 IFN-gamma (p 0.001) levels were significantly higher patients, as compared controls. Urinary TNF-alpha = 0.012 0.001), while LN 0.002). Measurement IL-6 could help predict

参考文章(17)
Tianfu Wu, Chun Xie, Hong W. Wang, Xin J. Zhou, Noa Schwartz, Sergio Calixto, Meggan Mackay, Cynthia Aranow, Chaim Putterman, Chandra Mohan, Elevated Urinary VCAM-1, P-Selectin, Soluble TNF Receptor-1, and CXC Chemokine Ligand 16 in Multiple Murine Lupus Strains and Human Lupus Nephritis The Journal of Immunology. ,vol. 179, pp. 7166- 7175 ,(2007) , 10.4049/JIMMUNOL.179.10.7166
Hye-Young Chun, Jae-Wook Chung, Hyoun-Ah Kim, Jeong-Moon Yun, Ja-Young Jeon, Young-Min Ye, Seung-Hyun Kim, Hae-Sim Park, Chang-Hee Suh, Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus Journal of Clinical Immunology. ,vol. 27, pp. 461- 466 ,(2007) , 10.1007/S10875-007-9104-0
Noa Schwartz, Lihe Su, Linda C. Burkly, Meggan Mackay, Cynthia Aranow, Maria Kollaros, Jennifer S. Michaelson, Brad Rovin, Chaim Putterman, Urinary TWEAK and the activity of lupus nephritis. Journal of Autoimmunity. ,vol. 27, pp. 242- 250 ,(2006) , 10.1016/J.JAUT.2006.12.003
Joyce Reyes-Thomas, Irene Blanco, Chaim Putterman, Urinary Biomarkers in Lupus Nephritis Clinical Reviews in Allergy & Immunology. ,vol. 40, pp. 138- 150 ,(2011) , 10.1007/S12016-010-8197-Z
Shinji Morimoto, Yoshiaki Tokano, Souichiro Nakano, Takashi Watanabe, Yoshihiro Tamayama, Akiko Mitsuo, Jun Suzuki, Hiroshi Kaneko, Iwao Sekigawa, Yoshinari Takasaki, Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis Autoimmunity. ,vol. 42, pp. 143- 149 ,(2009) , 10.1080/08916930802438790
J.I.M.C. Oates, Sanju Varghese, Alison M. Bland, Timothy P. Taylor, Sally E. Self, Romesh Stanislaus, Jonas S. Almeida, John M. Arthur, Prediction of urinary protein markers in lupus nephritis. Kidney International. ,vol. 68, pp. 2588- 2592 ,(2005) , 10.1111/J.1523-1755.2005.00730.X
N. SCHWARTZ, J. S. MICHAELSON, C. PUTTERMAN, Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis Annals of the New York Academy of Sciences. ,vol. 1109, pp. 265- 274 ,(2007) , 10.1196/ANNALS.1398.032
Pasquale Esposito, Mario M Balletta, Alfredo Procino, Loredana Postiglione, Bruno Memoli, Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Lupus. ,vol. 18, pp. 1329- 1330 ,(2009) , 10.1177/0961203309106183
Gabor G. Illei, Edward Tackey, Larissa Lapteva, Peter E. Lipsky, Biomarkers in systemic lupus erythematosus: II. Markers of disease activity Arthritis & Rheumatism. ,vol. 50, pp. 2048- 2065 ,(2004) , 10.1002/ART.20345
Martin Aringer, Josef S Smolen, The role of tumor necrosis factor-alpha in systemic lupus erythematosus Arthritis Research & Therapy. ,vol. 10, pp. 202- 202 ,(2008) , 10.1186/AR2341